Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$2.55 - $5.23 $26,157 - $53,649
-10,258 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$4.43 - $8.33 $45,442 - $85,449
10,258 New
10,258 $45,000
Q3 2021

Nov 12, 2021

SELL
$6.07 - $9.89 $142,645 - $232,415
-23,500 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$9.76 - $14.15 $229,360 - $332,525
23,500 New
23,500 $230,000

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.